Yang Gao

Yang Gao

Auto-generated profile, based on publicly available information

Yang Gao

Department of Cardiology, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital, 450000 Zhengzhou, Henan, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2025 in Reviews in Cardiovascular Medicine
Verified
Journal Article
Open access
QSQingbo Shi
Qingbo Shi
YGYang Gao
Yang Gao
ZSZhuocheng Shi
Zhuocheng Shi
MLMuwei Li
Muwei Li
Coronary heart disease (CHD), which is characterized by the coronary arteries narrowing or becoming obstructed due to atherosclerosis, leads to myocardial ischemia, hypoxia, or necrosis. Owing to an aging population and lifestyle changes, the incidence of CHD and subsequent mortality rates continue to rise, making CHD one of the leading causes of disability and death worldwide. Hypertension, diabetes, hyperlipidemia, smoking, obesity, and genetic factors are considered major risk factors for CHD; however, these factors do not fully explain the complexity and diversity in the etiology of CHD. Sleep, an indispensable part of human physiological processes, is crucial for maintaining physical and mental health. In recent years, the rapid pace of modern life has led to an increasing number of patients experiencing an insufficient amount of sleep, declining sleep quality, and sleep disorders. Therefore, the correlation between sleep and CHD has become a focal point in current research. This review aims to address the relationship between sleep duration, quality, and sleep disorder-related diseases with CHD and emphasizes potential underlying mechanisms and possible clinical implications. Moreover, this review aimed to provide a theoretical basis and clinical guidance for the prevention and treatment of CHD.

2 December 2025 in Clinical Cardiology
Verified
Journal Article
Open access
YGYang Gao
Yang Gao
QSQingbo Shi
Qingbo Shi
ZSZhuocheng Shi
Zhuocheng Shi
ZZZhiwen Zhang
Zhiwen Zhang
HYHaosen Yu
Haosen Yu
CMCao MA
Cao MA
Background: Insomnia is a prevalent sleep disorder increasingly recognized as a risk factor for cardiovascular diseases (CVDs). However, its causal relationship with myocardial infarction (MI) and its impact on coronary plaque vulnerability remain poorly understood. Methods: We performed Mendelian randomization (MR) analysis using genome‐wide association study (GWAS) summary data for insomnia ( n = 462,341) and MI ( n = 484,598) in populations of European descent. Additionally, 340 patients with coronary artery disease (CAD) underwent coronary angiography and optical coherence tomography (OCT) imaging. Insomnia was assessed by the Insomnia Severity Index (ISI), and OCT was used to evaluate plaque features including thin‐cap fibroatheroma (TCFA), fibrous cap thickness, lipid arc, macrophage infiltration, and plaque rupture. Results: MR analysis showed a potential causal effect of genetically predicted insomnia on MI risk (OR = 1.015; 95% CI: 1.004–1.027; p = 0.007), with no evidence of pleiotropy or heterogeneity. Clinically patients with insomnia (ISI ≥ 8) had higher rates of hypertension (54.3% vs. 39.6%) and MI (32.4% vs. 21.7%), elevated CRP levels, and exhibited greater plaque vulnerability on OCT, including increased incidence of TCFA (29.5% vs. 17.0%), thinner fibrous caps, larger lipid arcs, and more frequent macrophage infiltration and plaque rupture. Logistic regression identified both insomnia (OR = 1.806; p = 0.037) and CRP (OR = 1.384; p = 0.034) as independent predictors of TCFA. Conclusions: This study provides genetic and clinical evidence that insomnia contributes to MI risk and coronary plaque vulnerability, underscoring the importance of addressing sleep disturbances in CAD management.

6 October 2023 in Lupus
Verified
Journal Article
Closed access
YGYang Gao
Yang Gao
YWYunxia Wang
Yunxia Wang
MLMuwei Li
Muwei Li
CGChuanyu Gao
Chuanyu Gao
Background: Systemic lupus erythematosus (SLE) patients have a higher risk of acute myocardial infarction (AMI) compared to the general population. However, the underlying common mechanism of this association is not fully understood. This study aims to investigate the molecular mechanism of this complication. Methods: Gene expression profiles of SLE (GSE50772) and AMI (GSE66360) were obtained from the Gene Expression Omnibus (GEO) database. Common differentially expressed genes (DEGs) in SLE and AMI were identified, and functional annotation, protein-protein interaction (PPI) network analysis, module construction, and hub gene identification were performed. Additionally, transcription factor (TF)-gene regulatory network and TF-miRNA regulatory network were constructed for the hub genes. Results: 70 common DEGs (7 downregulated genes and 63 upregulated genes) were identified and were mostly enriched in signaling pathways such as the IL-17 signaling pathway, TNF signaling pathway, lipid metabolism, and atherosclerosis. Using cytoHubba, 12 significant hub genes were identified, including IL1B, TNF, FOS, CXCL8, JUN, PTGS2, FN1, EGR1, CXCL1, DUSP1, MMP9, and ZFP36. Conclusions: This study reveals a common pathogenesis of SLE and AMI and provides new perspectives for further mechanism research. The identified common pathways and hub genes may have important clinical implications for the prevention and treatment of AMI in SLE patients.

12 November 2025 in Reviews in Cardiovascular Medicine
Verified
Journal Article
Open access
QSQingbo Shi
Qingbo Shi
YGYang Gao
Yang Gao
ZZZhiwen ZHANG
Zhiwen ZHANG
ZSZhuocheng Shi
Zhuocheng Shi
HYHaosen Yu
Haosen Yu
MLMuwei Li
Muwei Li
Background: Previous studies have shown a strong link between sleep and cardiovascular disease. However, the association of sleep duration and quality with coronary atherosclerotic plaque vulnerability remains unclear. This study aimed to investigate the correlation between sleep duration, sleep quality, and coronary plaque vulnerability using optical coherence tomography (OCT). Methods: A total of 260 patients with stable angina who completed an OCT examination were included. Patients were divided into a thin-cap fibroatheroma (TCFA) group and a non-TCFA group according to the presence of TCFA on OCT. The sleep duration of the patients was recorded by questionnaire, and the sleep quality was evaluated using the Pittsburgh Sleep Quality Index (PSQI). Results: The TCFA group had significantly shorter sleep duration and higher PSQI values (p < 0.05). A multivariable logistic regression analysis revealed that sleep duration and PSQI were independent predictors of TCFA (p < 0.05). A receiver operating characteristic (ROC) study demonstrated that the area under the curve values for sleep duration and PSQI were 0.698 and 0.721, respectively, in predicting the presence of TCFA. Patients with a sleep duration ≤5.5 hours or a PSQI value >9 had a thinner fibrous cap thickness, a larger maximal lipid pool arc, and a higher incidence of TCFA and macrophage deposition (p < 0.05). Sleep duration was positively correlated with the thinnest fibrous cap thickness (r = 0.451; p < 0.001), and negatively correlated with the radian of the maximum lipid pool (r = –0.470; p < 0.001). The PSQI was negatively correlated with the thinnest fibrous cap thickness (r = –0.477; p < 0.001), and positively correlated with the radian of maximum lipid pool (r = 0.340; p < 0.001). Conclusion: Both sleep duration and sleep quality were significantly associated with coronary plaque vulnerability. Patients with either insufficient sleep duration or poor sleep quality exhibited significantly greater plaque vulnerability.